The main focus of the research group is in translational research in gynaecological cancers. In particular biomarker discovery and development (specifically immunological markers) in ovarian and endometrial cancers. The biomarkers are now in the process of being tested for diagnosis and surgical prognosis. The concept of predicting surgical outcome in ovarian cancer is a step in developing personalised medicine and providing patients with best care possible.
Recent advances in oncolgy have improved survival in patients with cancer but research into surgery may have additional benefits for the patient. Clinical research into optimal treatment of cervival preinvasive lesions has been a focus. We have shown that clear margins of resection has a significant effect on reducing risk of recurrence from preinvasive disease.
et al., 2021, Diagnostic accuracy of FEC-PET/CT, FDG-PET/CT and diffusion-weighted MRI in detection of nodal metastases in surgically treated endometrial and cervical carcinoma, Clinical Cancer Research, ISSN:1078-0432
et al., 2021, A novel application of calcium electroporation to cutaneous manifestations of gynaecological cancer, European Journal of Gynecological Oncology, Vol:42, ISSN:0392-2936, Pages:662-672
et al., 2021, Uterine Transplantation: Review of Livebirths and Reproductive Implications, Transplantation, Vol:105, ISSN:0041-1337, Pages:1695-1707
et al., 2021, Anxiety and stress in women with suspected endometrial cancer: Survey and paired observational study, Psycho-oncology: Journal of the Psychological, Social and Behavioral Dimensions of Cancer, Vol:30, ISSN:1057-9249, Pages:1939-1400
Keefe D, 2021, Fertility Treatment and Cancers-The Eternal Conundrum: A Systematic Review and Meta-analysis, Obstetrical & Gynecological Survey, Vol:76, ISSN:0029-7828, Pages:343-344